ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
JMI Hospital Requisite Manufacturing ROE % Related Terms
JMI Hospital Requisite Manufacturing ROE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JMI Hospital Requisite Manufacturing ROE % Chart
JMI Hospital Requisite Manufacturing Annual Data
Trend
Jun21
Jun22
Jun23
Jun24
Jun25
ROE %
7.94
9.68
7.65
7.08
5.39
JMI Hospital Requisite Manufacturing Quarterly Data
For the Medical Instruments & Supplies subindustry, JMI Hospital Requisite Manufacturing's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JMI Hospital Requisite Manufacturing ROE % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, JMI Hospital Requisite Manufacturing's ROE % distribution charts can be found below:
* The bar in red indicates where JMI Hospital Requisite Manufacturing's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
JMI Hospital Requisite Manufacturing (DHA:JHRML) has a ROE % of 2.02% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on JMI Hospital Requisite Manufacturing and its competitors. This is 74% below median its historical median of 7.65. Over the past decade, JMI Hospital Requisite Manufacturing's ROE % has ranged from 2.76 to 9.68. According to the industry distribution chart, JMI Hospital Requisite Manufacturing ranks #390 out of 796 companies in the Medical Devices & Instruments industry, placing it in the top 49%.
Is JMI Hospital Requisite Manufacturing's ROE % too high?
JMI Hospital Requisite Manufacturing's current ROE % of 2.02% is 74% below median its 10-year median of 7.65. Over the past 10 years, this metric has ranged from a low of 2.76 to a high of 9.68. The Medical Devices & Instruments industry median ROE % is 2.41. JMI Hospital Requisite Manufacturing's value of 2.02% is 16.2% below this industry median. Based on the distribution chart, JMI Hospital Requisite Manufacturing ranks #390 out of 796 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, JMI Hospital Requisite Manufacturing has a GF Score™ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does JMI Hospital Requisite Manufacturing's ROE % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, JMI Hospital Requisite Manufacturing ranks #390 out of 796 companies for ROE %. This puts JMI Hospital Requisite Manufacturing in the upper half of its industry. The industry median ROE % is 2.41. JMI Hospital Requisite Manufacturing's value of 2.02% is 16.2% below this benchmark. Historically, JMI Hospital Requisite Manufacturing's own ROE % has ranged from 2.76 to 9.68 over the past decade. While the company's 10-year median is 7.65 vs. the industry median of 2.41, JMI Hospital Requisite Manufacturing has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Medical Devices & Instruments company?
The median ROE % among Medical Devices & Instruments companies is 2.41, based on 796 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JMI Hospital Requisite Manufacturing's current ROE % of 2.02% is 16.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on JMI Hospital Requisite Manufacturing and its competitors. For the Medical Devices & Instruments industry, the median ROE % is 2.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JMI Hospital Requisite Manufacturing's current ROE % is 2.02%, which is 74% below median its own 10-year median of 7.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JMI Hospital Requisite Manufacturing stock overvalued right now?
Based on GuruFocus' analysis, JMI Hospital Requisite Manufacturing (DHA:JHRML) is currently considered Fairly Valued. The stock's GF Value™ is BDT50.92, compared to a current price of BDT52.60 — trading 3.3% above its estimated fair value. The current ROE % is 2.02%, which is 74% below median its 10-year median of 7.65 and 16.2% below the Medical Devices & Instruments industry median of 2.41. JMI Hospital Requisite Manufacturing's overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For JMI Hospital Requisite Manufacturing (DHA:JHRML), the current ROE % is 2.02% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JMI Hospital Requisite Manufacturing (DHA:JHRML) Overvalued in 2026?
Based on GuruFocus' analysis, JMI Hospital Requisite Manufacturing stock appears to be overvalued.
The current stock price of BDT52.60 is trading 3.3% above its estimated GF Value™ of BDT50.92.
GuruFocus considers JMI Hospital Requisite Manufacturing to be Fairly Valued.
Key valuation signals for DHA:JHRML:
ROE %: 2.02% (74% below median its 10-year median of 7.65)
GF Value™: BDT50.92 vs. price of BDT52.60 (3.3% above fair value)
Industry Position: 16.2% below the Medical Devices & Instruments median (#390 of 796)
No single metric tells the full story. See the DHA:JHRML stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JMI Hospital Requisite Manufacturing Business Description
JMI Hospital Requisite Manufacturing Ltd is engaged in the production of medical devices and components. The company produces health & hospicare products. The products of the company include Surgical Sutures, Surgical Gloves, IV Cannula, Bulk Needles, Blister Film, Infusion Set Components, Disposable Scalpels, Nasal Oxygen Cannulas, Blood Transfusion Sets, Urine Drainage Bags, Scalp Vein Sets, and others.
67GF Score
Get the complete analysis for DHA:JHRML
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHA:JHRML has been successfully added to your 
